Discovery of small molecule agonists for the bombesin receptor subtype 3 (BRS-3) based on an omeprazole lead-Reference-Cited by-同舟云学术

Discovery of small molecule agonists for the bombesin receptor subtype 3 (BRS-3) based on an omeprazole lead

Published:2008-10 Issue:20 Volume:18 Page:5451-5455
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Carlton David L.,Collin-Smith Lissa J.,Daniels Alejandro J.,Deaton David N.,Goetz Aaron S.,Laudeman Christopher P.,Littleton Thomas R.,Musso David L.,Morgan Ronda J. Ott,Szewczyk Jerzy R.,Zhang Cunyu

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference24 articles.

1. How many drug targets are there?

2. BRS-3: a novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells.

3. International Union of Pharmacology. LXVIII. Mammalian Bombesin Receptors: Nomenclature, Distribution, Pharmacology, Signaling, and Functions in Normal and Disease States

4. Two distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma cells.

5. Characterization of the bombesin-like peptide receptor family in primates

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Passion types and life satisfaction among older adult Moroccans: Reliability of scores and mediation by resilience;Journal of Psychology in Africa;2024-01-02

2. N1-Substituted benzimidazole scaffold for farnesoid X receptor (FXR) agonists accompanying prominent selectivity against vitamin D receptor (VDR);Bioorganic & Medicinal Chemistry;2020-07

3. Reviewing Hit Discovery Literature for Difficult Targets: Glutathione Transferase Omega-1 as an Example;Journal of Medicinal Chemistry;2018-04-13

4. Bombesin receptor subtype 3 as a potential target for obesity and diabetes;Expert Opinion on Therapeutic Targets;2015-06-12

5. Biology and pharmacology of bombesin receptor subtype-3;Current Opinion in Endocrinology, Diabetes & Obesity;2012-02